BAL PHARMA
Back to Cashflow Statement
|
BAL PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-7.84 Cr | ₹-1.21 Cr | ₹24 Cr | ₹-17 Cr | ₹-17 Cr |
What is the latest Cash Flow from Financing Activities ratio of BAL PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-7.84 Cr |
Mar2024 | ₹-1.21 Cr |
Mar2023 | ₹24 Cr |
Mar2022 | ₹-17 Cr |
Mar2021 | ₹-17 Cr |
How is Cash Flow from Financing Activities of BAL PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-7.84 Cr | Negative | |
Mar2024 | ₹-1.21 Cr | Negative | |
Mar2023 | ₹24 Cr | Positive | |
Mar2022 | ₹-17 Cr | Negative | |
Mar2021 | ₹-17 Cr | - |
Compare Cash Flow from Financing Activities of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹131.6 Cr | -3.5% | -3.1% | -31.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,666.0 Cr | -3.5% | 0% | -12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,060.0 Cr | -6.6% | -7.2% | 9.8% | Stock Analytics | |
CIPLA | ₹121,080.0 Cr | -2.8% | -5% | -7.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,605.0 Cr | -2.5% | -0.4% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,556.0 Cr | -3.8% | -0.6% | -4.2% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | -3.5% |
-3.1% |
-31.8% |
SENSEX | -2.7% |
-0.5% |
-5.3% |
You may also like the below Video Courses